- Home
- Publications
- Publication Search
- Publication Details
Title
Rhabdomyosarcoma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-08
DOI
10.1038/s41572-018-0051-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors
- (2018) Catherine J. Drummond et al. CANCER CELL
- Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): A report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
- (2018) Gianni Bisogno et al. JOURNAL OF CLINICAL ONCOLOGY
- More than Grapes and Bleeding: An Updated Look at Pelvic Rhabdomyosarcoma in Young Women
- (2018) Aalia Sachedina et al. Journal of Pediatric and Adolescent Gynecology
- Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
- (2018) Gianni Bisogno et al. LANCET ONCOLOGY
- SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function
- (2018) Klaudia Skrzypek et al. Cell Death & Disease
- Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes
- (2018) Lin Xu et al. Cell Reports
- Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach
- (2018) Dana Casey et al. Journal of Neurological Surgery Part B-Skull Base
- Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma
- (2018) Amanda F. Saltzman et al. Current Urology Reports
- Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
- (2018) Elizabeth Stewart et al. CANCER CELL
- Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute.
- (2018) John Frederick Shern et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group
- (2018) Douglas S. Hawkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular diagnostics in the management of rhabdomyosarcoma
- (2017) Michael A. Arnold et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center
- (2017) Sophia Marie Häußler et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
- (2017) Francesca Megiorni et al. Journal of Hematology & Oncology
- Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial
- (2017) Carl E. Allen et al. JNCI-Journal of the National Cancer Institute
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
- (2017) Berkley E. Gryder et al. Cancer Discovery
- The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma
- (2017) Myron S. Ignatius et al. Cell Reports
- Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial
- (2017) Carl E. Allen et al. JNCI-Journal of the National Cancer Institute
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Quality of life and functional outcome of male patients with bladder–prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood
- (2016) Hélène Martelli et al. Brachytherapy
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma
- (2016) Beatrice Conti et al. CURRENT DRUG TARGETS
- Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma
- (2016) Daniel D. Shapiro et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma
- (2016) Maria Böhm et al. JOURNAL OF CLINICAL INVESTIGATION
- Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2016) Brenda J. Weigel et al. JOURNAL OF CLINICAL ONCOLOGY
- P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma
- (2016) Narendra Bharathy et al. JOURNAL OF PATHOLOGY
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
- (2016) Anita Villani et al. LANCET ONCOLOGY
- MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells
- (2016) Osamu Otabe et al. ONCOLOGY REPORTS
- Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group
- (2016) Michael A. Arnold et al. PEDIATRIC BLOOD & CANCER
- Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
- (2016) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma
- (2016) Roshni Dasgupta et al. Seminars in Pediatric Surgery
- Current standards of care in bladder and prostate rhabdomyosarcoma
- (2016) Kathleen Kieran et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Erectile function after treatment for rhabdomyosarcoma of prostate and bladder
- (2016) S. Frees et al. Journal of Pediatric Urology
- Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates
- (2015) Sara E. Lychou et al. ACTA PAEDIATRICA
- The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2015) Erin R. Rudzinski et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
- (2015) Sidi Chen et al. CELL
- Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group
- (2015) P. Hingorani et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Rhabdomyosarcoma in Adults: New Perspectives on Therapy
- (2015) Catalina Ruiz-Mesa et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study
- (2015) Joanne Wolfe et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma
- (2015) S Satheesha et al. ONCOGENE
- Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2015) AeRang Kim et al. PEDIATRIC BLOOD & CANCER
- Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
- (2015) Masafumi Seki et al. Nature Communications
- Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression
- (2015) Klaudia Skrzypek et al. Oncotarget
- Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database
- (2015) Philip J. Lupo et al. Cancer Medicine
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
- (2015) Katherine K. Slemmons et al. PLoS One
- Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma
- (2014) Erin R. Rudzinski et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone
- (2014) Leona A. Doyle CANCER
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children’s Oncology Group
- (2014) Philip J. Lupo et al. CANCER CAUSES & CONTROL
- The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation
- (2014) Annie M. Tremblay et al. CANCER CELL
- PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
- (2014) V. Thalhammer et al. CANCER RESEARCH
- Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness
- (2014) Sara Chiappalupi et al. CARCINOGENESIS
- Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
- (2014) David A. Rodeberg et al. INTERNATIONAL JOURNAL OF CANCER
- FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells
- (2014) Marco Wachtel et al. INTERNATIONAL JOURNAL OF CANCER
- Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- (2014) David O. Walterhouse et al. JOURNAL OF CLINICAL ONCOLOGY
- Parental Military Service, Agent Orange Exposure, and the Risk of Rhabdomyosarcoma in Offspring
- (2014) Seymour Grufferman et al. JOURNAL OF PEDIATRICS
- A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
- (2014) Shinji Kohsaka et al. NATURE GENETICS
- Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group
- (2014) Lars M. Wagner et al. PEDIATRIC BLOOD & CANCER
- Glycogen synthase kinase 3 inhibitors induce the canonical WNT/ -catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
- (2014) E. Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
- (2014) J. F. Shern et al. Cancer Discovery
- Classification of Rhabdomyosarcoma and Its Molecular Basis
- (2013) David M. Parham et al. ADVANCES IN ANATOMIC PATHOLOGY
- Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma
- (2013) Erin R. Rudzinski et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
- (2013) Xiang Chen et al. CANCER CELL
- Distinct Effects of Ligand-Induced PDGFR and PDGFR Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments
- (2013) M. Ehnman et al. CANCER RESEARCH
- Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
- (2013) J. Renshaw et al. CLINICAL CANCER RESEARCH
- Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: A report from the children's oncology group
- (2013) Philip J. Lupo et al. INTERNATIONAL JOURNAL OF CANCER
- Alveolar rhabdomyosarcoma–associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression
- (2013) Lisa E.S. Crose et al. JOURNAL OF CLINICAL INVESTIGATION
- Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma
- (2013) Srinivas R Annavarapu et al. LABORATORY INVESTIGATION
- Genome-wide association study identifies two susceptibility loci for osteosarcoma
- (2013) Sharon A Savage et al. NATURE GENETICS
- The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)
- (2013) R Ciarapica et al. ONCOGENE
- JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
- (2013) Z S Walters et al. ONCOGENE
- Multilayer control of the EMT master regulators
- (2013) H Zheng et al. ONCOGENE
- Myoepithelial carcinoma treatment in children: A report from the TREP project
- (2013) Gianni Bisogno et al. PEDIATRIC BLOOD & CANCER
- PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma
- (2013) Tobias M. Dantonello et al. PEDIATRIC BLOOD & CANCER
- The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation
- (2013) K Miekus et al. Cell Death & Disease
- A Mouse Model of Rhabdomyosarcoma Originating from the Adipocyte Lineage
- (2012) Mark E. Hatley et al. CANCER CELL
- FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
- (2012) L. E. S. Crose et al. CLINICAL CANCER RESEARCH
- Radiotherapy for Rhabdomyosarcoma: Indications and Outcome
- (2012) S.A. Terezakis et al. CLINICAL ONCOLOGY
- Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
- (2012) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors
- (2012) K. L. MacQuarrie et al. MOLECULAR AND CELLULAR BIOLOGY
- Snail Regulates MyoD Binding-Site Occupancy to Direct Enhancer Switching and Differentiation-Specific Transcription in Myogenesis
- (2012) Vahab D. Soleimani et al. MOLECULAR CELL
- Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
- (2012) Sophie Postel-Vinay et al. NATURE GENETICS
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas
- (2012) Douglas S. Hawkins et al. PEDIATRIC BLOOD & CANCER
- Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis
- (2012) Amy D Marshall et al. Skeletal Muscle
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes
- (2011) Christian P. Kratz et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Rhabdomyosarcoma in infants younger than 1 year
- (2011) Suman Malempati et al. CANCER
- Sarcomas in TP53 germline mutation carriers
- (2011) Simona Ognjanovic et al. CANCER
- Histone Methyltransferase KMT1A Restrains Entry of Alveolar Rhabdomyosarcoma Cells into a Myogenic Differentiated State
- (2011) M.-H. Lee et al. CANCER RESEARCH
- PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis
- (2011) A. D. Marshall et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways
- (2011) N. Shukla et al. CLINICAL CANCER RESEARCH
- Prognostic Significance and Tumor Biology of Regional Lymph Node Disease in Patients With Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2011) David A. Rodeberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaginal tumors in childhood: the experience of St. Jude Children's Research Hospital
- (2011) Israel Fernandez-Pineda et al. JOURNAL OF PEDIATRIC SURGERY
- Rhabdomyosarcoma in Children: A SEER Population Based Study
- (2011) Eduardo A. Perez et al. JOURNAL OF SURGICAL RESEARCH
- Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma
- (2011) J. Abraham et al. MOLECULAR CANCER THERAPEUTICS
- DICER1 Mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome
- (2011) Leslie Doros et al. PEDIATRIC BLOOD & CANCER
- Childhood cancer in relation to parental race and ethnicity
- (2010) Eric J. Chow et al. CANCER
- Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
- (2010) L. Cao et al. CANCER RESEARCH
- Proton Radiotherapy for Pediatric Bladder/Prostate Rhabdomyosarcoma: Clinical Outcomes and Dosimetry Compared to Intensity-Modulated Radiation Therapy
- (2010) Shane E. Cotter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group
- (2010) Elai Davicioni et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma
- (2010) A Zibat et al. ONCOGENE
- Sexual function in teenagers after multimodal treatment of pelvic rhabdomyosarcoma: A preliminary report
- (2010) Antonio Macedo et al. Journal of Pediatric Urology
- High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human Myoblasts
- (2009) Shujuan J. Xia et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005
- (2009) Simona Ognjanovic et al. CANCER
- Prenatal X-ray Exposure and Rhabdomyosarcoma in Children: A Report from the Children's Oncology Group
- (2009) S. Grufferman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma
- (2009) Gianni Bisogno et al. EUROPEAN JOURNAL OF CANCER
- RAS signaling dysregulation in human embryonal Rhabdomyosarcoma
- (2009) Simone Martinelli et al. GENES CHROMOSOMES & CANCER
- Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
- (2009) Iyad Sultan et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of bone tumours in children and young adults
- (2009) Rachel Eyre et al. PEDIATRIC BLOOD & CANCER
- Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
- (2008) Y.-X. Ren et al. CANCER RESEARCH
- Phosphorylation Regulates Transcriptional Activity of PAX3/FKHR and Reveals Novel Therapeutic Possibilities
- (2008) R. Amstutz et al. CANCER RESEARCH
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
- (2008) S. Naini et al. CANCER RESEARCH
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
- (2008) E Taniguchi et al. ONCOGENE
- Treating Pediatric soft tissue sarcomas in a country with limited resources: The experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala
- (2008) Federico Antillon et al. PEDIATRIC BLOOD & CANCER
- Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma
- (2007) Ken Kikuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started